Skip to main content

Expression Analysis to Use GeneGo Software for Functional Analysis Service

NEW YORK (GenomeWeb News) — Genomic services firm Expression Analysis will use GeneGo’s 1-2-3-Workflow technology to provide functional analysis of pathways and networks as add-on services, GeneGo said today.
 
Under the multi-year agreement, Expression Analysis will submit to GeneGo data from various customers, including pharmaceutical companies, biotechs, and academic institutions, Julie Bryant, GeneGo’s vice president of business development and marketing, said in a statement.
 
GeneGo’s 1-2-3-Workflow compares multiple expression datasets, conducts enrichment analyses in multiple areas such as disease, pathways, and processes, and provides other analytical services. It returns these data in a Microsoft Word document within 24 hours.
 
Financial terms of the agreement were not released.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.